Capital Solutions

We advise on and arrange financing for companies, owners, lenders and investors.

Our work covers debt and equity capital, from a business as a whole to a single asset. We may also invest our own capital, independently or alongside clients and partners.

Financing can support acquisitions, expansion, project development, working capital and the refinancing of existing obligations.

Two people talking on an elevated walkway, in silhouette against office towers

Our Work

  • Debt and equity capital
  • Corporate and project financing
  • Asset-based financing
  • Lease financing and sale and leaseback

How We Work

We help define the funding requirement and identify prospective capital providers. We coordinate the information they need to assess an opportunity.

Our role can include comparing proposals and structuring transactions. We lead commercial negotiations and manage the process through to financial close. Each assignment is shaped around the requirement and the parties involved.

Who We Work With

  • Businesses and their owners
  • Banks and other lenders
  • Lessors and asset managers
  • Private and institutional investors

Selected Experience

Aircraft Engine Sale and Leaseback

Originated, structured and negotiated the sale and leaseback of three engines for an Asia-based airline, releasing working capital during a period of oil-price volatility.

Completed: 2026
Value: US$30 million+

Critical Minerals Offtake Investment

Originated a strategic investment in an antimony project in Africa. The buyer funds the project's start-up in return for guaranteed offtake.

Ongoing: since 2025
Value: US$7.5 million+

Rice Supply Investment

Originated and structured an investment in rice production for a Middle East buyer, securing supply and diversifying its sources. We negotiated the terms between the parties.

Ongoing: since 2026
Value: US$10 million+

Artemisinin Joint Venture

Brought together Korean and Vietnamese partners in a joint venture to produce artemisinin, the plant-derived active ingredient in antimalarial treatments.

Ongoing: since 2025
Value: Confidential

Discuss a Financing Requirement

Contact us to discuss a financing requirement or capital investment opportunity.

Contact Us